InflaRx NV (InflaRx NV) Days Payable : 4,071.51 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is InflaRx NV Days Payable?

InflaRx NV's average Accounts Payable for the three months ended in Mar. 2024 was $10.66 Mil. InflaRx NV's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.24 Mil. Hence, InflaRx NV's Days Payable for the three months ended in Mar. 2024 was 4,071.51.

The historical rank and industry rank for InflaRx NV's Days Payable or its related term are showing as below:

IFRX' s Days Payable Range Over the Past 10 Years
Min: 3439.62 Med: 5771.41 Max: 5771.41
Current: 3439.62

During the past 9 years, InflaRx NV's highest Days Payable was 5771.41. The lowest was 3439.62. And the median was 5771.41.

IFRX's Days Payable is ranked better than
91.93% of 719 companies
in the Biotechnology industry
Industry Median: 147.29 vs IFRX: 3439.62

InflaRx NV's Days Payable increased from Mar. 2023 (0.00) to Mar. 2024 (4,071.51). It may suggest that InflaRx NV delayed paying its suppliers.

InflaRx NV Days Payable Historical Data

The historical data trend for InflaRx NV's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InflaRx NV Days Payable Chart

InflaRx NV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

5,771.41

InflaRx NV Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															-	-	2,019.07	2,939.94	4,071.51

Competitive Comparison of InflaRx NV's Days Payable

For the Biotechnology subindustry, InflaRx NV's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InflaRx NV's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InflaRx NV's Days Payable distribution charts can be found below:

* The bar in red indicates where InflaRx NV's Days Payable falls into.

InflaRx NV Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

InflaRx NV's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (5.284	+	13.058)	/	2 )	/	0.58	*	365
=	9.171					/	0.58	*	365
=	5,771.41

InflaRx NV's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (13.058	+	8.27)	/	2 )	/	0.239	*	365 / 4
=	10.664					/	0.239	*	365 / 4
=	4,071.51

InflaRx NV Days Payable Related Terms

Thank you for viewing the detailed overview of InflaRx NV's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

InflaRx NV (InflaRx NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InflaRx NV (NAS:IFRX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

IF0:Germany IF0:Germany

Address

Winzerlaer Strasse 2, Jena, DEU, 07745

Website

https://www.inflarx.de

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.